Total Payments
$343,218
2024 Payments
$6,874
Companies
88
Transactions
1,783
Medicare Patients
3,800
Medicare Billing
$836,561
Payment Breakdown by Category
Other$277,670 (80.9%)
Food & Beverage$31,467 (9.2%)
Travel$25,886 (7.5%)
Consulting$7,863 (2.3%)
Education$213.12 (0.1%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $274,020 | 163 | 79.8% |
| Food and Beverage | $31,467 | 1,490 | 9.2% |
| Travel and Lodging | $25,886 | 99 | 7.5% |
| Consulting Fee | $7,863 | 7 | 2.3% |
| Honoraria | $3,650 | 3 | 1.1% |
| Education | $213.12 | 19 | 0.1% |
| Gift | $118.80 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $86,079 | 207 | $0 (2024) |
| Novo Nordisk Inc | $78,375 | 294 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $64,951 | 159 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $48,139 | 100 | $0 (2023) |
| Mannkind Corporation | $18,319 | 116 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $9,535 | 13 | $0 (2023) |
| Abbott Laboratories | $7,525 | 64 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $5,698 | 21 | $0 (2024) |
| Clarus Therapeutics Inc. | $3,952 | 8 | $0 (2021) |
| Orexigen Therapeutics, Inc. | $2,397 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,874 | 168 | Mannkind Corporation ($1,892) |
| 2023 | $43,979 | 274 | Lilly USA, LLC ($28,364) |
| 2022 | $69,979 | 289 | Lilly USA, LLC ($56,433) |
| 2021 | $24,240 | 236 | Novo Nordisk Inc ($7,667) |
| 2020 | $22,654 | 143 | Novo Nordisk Inc ($8,581) |
| 2019 | $46,517 | 214 | Novo Nordisk Inc ($24,288) |
| 2018 | $67,862 | 224 | AstraZeneca Pharmaceuticals LP ($25,532) |
| 2017 | $61,112 | 235 | AstraZeneca Pharmaceuticals LP ($26,075) |
All Payment Transactions
1,783 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Bone Health | ||||||
| 12/14/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/13/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $32.80 | General |
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: PAIN | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PAIN | ||||||
| 11/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,004 | 32,092 | $1.1M | $368,664 |
| 2022 | 9 | 969 | 15,069 | $658,544 | $223,932 |
| 2021 | 10 | 988 | 8,798 | $451,661 | $161,797 |
| 2020 | 9 | 839 | 2,895 | $230,594 | $82,167 |
Total Patients
3,800
Total Services
58,854
Medicare Billing
$836,561
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 23 | 25,365 | $710,220 | $202,021 | 28.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 55 | 5,400 | $237,600 | $99,164 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 509 | $70,242 | $29,734 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 279 | $56,916 | $22,786 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $18,912 | $7,264 | 38.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 76 | 216 | $14,904 | $2,264 | 15.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $5,480 | $2,032 | 37.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 211 | 211 | $6,963 | $1,924 | 27.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 31 | $2,573 | $1,014 | 39.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $3,757 | $461.50 | 12.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 53 | 4,740 | $208,560 | $80,685 | 38.7% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 12 | 9,034 | $252,952 | $67,950 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 415 | $84,660 | $34,857 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 333 | 504 | $69,552 | $29,610 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $12,608 | $4,664 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,804 | $1,507 | 39.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 155 | 155 | $9,979 | $1,435 | 14.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 59 | 126 | $8,694 | $1,361 | 15.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 34 | $2,822 | $1,271 | 45.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 16 | 17 | $4,913 | $593.43 | 12.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 39 | 3,600 | $158,400 | $58,736 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 256 | 373 | $76,092 | $33,504 | 44.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2021 | 11 | 3,901 | $109,228 | $28,427 | 26.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 287 | 416 | $57,408 | $25,384 | 44.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 48 | 48 | $18,912 | $7,108 | 37.6% |
About Dr. Michael Sokol, MD
Dr. Michael Sokol, MD is a Internal Medicine healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235163676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sokol, MD has received a total of $343,218 in payments from pharmaceutical and medical device companies, with $6,874 received in 2024. These payments were reported across 1,783 transactions from 88 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($274,020).
As a Medicare-enrolled provider, Sokol has provided services to 3,800 Medicare beneficiaries, totaling 58,854 services with total Medicare billing of $836,561. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Overland Park, KS
- Active Since 07/10/2006
- Last Updated 06/23/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235163676
Products in Payments
- MOUNJARO (Drug) $71,123
- FARXIGA (Drug) $56,924
- INVOKANA (Drug) $47,891
- AFREZZA (Drug) $18,319
- Saxenda (Drug) $17,398
- Ozempic (Drug) $16,666
- Victoza (Drug) $11,898
- ZENPEP (Drug) $10,885
- Tresiba (Drug) $8,783
- RYBELSUS (Drug) $7,891
- BYDUREON (Drug) $7,371
- FREESTYLE LIBRE 3 (Device) $6,750
- Kerendia (Drug) $5,698
- JATENZO (Drug) $3,980
- CONTRAVE (Drug) $2,548
- TEPEZZA (Drug) $1,686
- EVENITY (Biological) $800.81
- Vascepa (Drug) $797.91
- JARDIANCE (Drug) $778.51
- Korlym (Drug) $615.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Overland Park
Dr. Herbert Waxman, M.d, M.D
Internal Medicine — Payments: $344,541
Internal Medicine $344,541
Kevin Suttmoeller, D.o, D.O
Internal Medicine — Payments: $182,553
Internal Medicine $182,553
Dr. Ajjai Alva, M.d, M.D
Internal Medicine — Payments: $95,044
Internal Medicine $95,044
Lisa Vansaghi, M.d, M.D
Internal Medicine — Payments: $43,826
Internal Medicine $43,826
Shadrach Smith, M.d, M.D
Internal Medicine — Payments: $43,616
Internal Medicine $43,616
Pouyan Arman, M.d, M.D
Internal Medicine — Payments: $31,107
Internal Medicine $31,107